Latest Content

Patients with cancer are referred for psychosocial support to address emotional distress and mental health needs, according to a new study.

Shondia McFadden-Sabari of Bold and Breastless shares how intuition and early detection saved her life during a dual breast cancer diagnosis.

Talzenna plus Xtandi improved progression-free survival in metastatic prostate cancer, delaying disease worsening in a phase 3 trial.

New strategies in mCRPC focus on sequencing, genomics and earlier use of targeted therapies to improve outcomes for patients.

A phase 3 study shows pimicotinib shrinks tumors and improves pain, stiffness and mobility in adults with unresectable tenosynovial giant cell tumors.

Paul, a liver cancer survivor, and his wife Emma share their journey of recovery, caregiving and finding balance in life after major surgeries.

Rosemary Carrera discusses her breast cancer journey, mastectomy and the personal decision to remove her implants at the Miami Breast Cancer Conference.

NCCN guidelines now include plus BCG for certain BCG-unresponsive bladder cancer patients, expanding treatment options.

The FOURLIGHT-1 study found that atirmociclib plus Faslodex significantly improved progression-free survival in patients with HR+/HER2- metastatic breast cancer.

Dr. Joseph Mikhael, chief medical officer of the International Myeloma Foundation, provided updates from the front lines of treatment advancement.

Dr. Marleen Meyers discusses improving survival rates, the evolving needs of younger cancer survivors and how caregivers can sustain long-term support.

New FDA approvals target mutations in lung cancer, improving outcomes, while clinicians refine strategies to manage immunotherapy-related side effects.

Though I don’t understand why I’m suffering, I try to hold onto my faith and believe that God is somehow still working in me.